Immunosenescence and immune response in organ transplantation

International Reviews of Immunology

Volumn 33, Issue 3, 2014, Pages 162-173

  Martins, Paulo Ney Aguiar ^a   Tullius, Stefan G ^b   Markmann, James F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aging; Elderly; Immunosenescence; Transplantation

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

AGING; CELL SUBPOPULATION; DENDRITIC CELL; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSENESCENCE; MEMORY CELL; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SENESCENCE; TRANSPLANTATION TOLERANCE; ADVERSE EFFECTS; AGE; HISTOCOMPATIBILITY; IMMUNOLOGY; PROCEDURES;

AGE FACTORS; AGING; GRAFT REJECTION; HUMANS; IMMUNE SYSTEM; ORGAN TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 84900848763     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2013.829469     Document Type: Review

References (143)

1. Department of Economic and Social Affairs Population Division. World population ageing 1950-2050. United Nations, 2002. pp. 15-22.
2. OPTN home page. Available at: http://optn.transplant.hrsa.gov/data/. DataaccessedFebruary26thof2013.
3. Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Ageing Dev 1999;108(1):1-7. (Pubitemid 29210235)
4. Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000;31(2):578-585. (Pubitemid 32289594)
5. Martins PN, Pratschke J, Pascher A, et al. Aging and immune response in organ transplantation. Transplantation 2005;79(2):127-132.
6. Epstein M. Aging and the kidney. J Am Soc Nephrol 1996;7(8):1106-1122. (Pubitemid 27468261)
7. Halloran PF,Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999;10(1):167-181. (Pubitemid 29034957)
8. Ginaldi L, De Martinis M, D'Ostilio A, et al. Immunological changes in the elderly. Aging 1999;11(5):281-286.
9. Globerson A, Effros RB. Ageing of lymphocytes and lymphocytes in the aged. Immunol Today 2000;21(10):515-521.
10. Geiger H, Van Zant G. The aging of lympho-hematopoietic stem cells. Nat Immunol 2002;3(4):329-333. (Pubitemid 34308614)
11. Beerman I, Maloney WJ, Weissmann IL, Rossi DJ. Stem cells and the aging hematopoietic system. Curr Opin Immunol 2010a;22(4):500-506.
12. Cossarizza A, Ortolani C, Monti D, Francheschi C. Cytometric analysis of immunosenescence. Cytometry 1997;27(4):297.
13. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004;5(2):133-139. (Pubitemid 38208354)
14. Lethonen L, Eskola J, Vanio O, Lethonen A. Changes in lymphocyte subsets and immune competence in very advanced age. J Gerontol 1990;45(3):M108-112. (Pubitemid 20171162)
15. Naylor K, Li G, Vallejo AN, et al. The influence of age on T cell generation and TCR diversity. J Immunol 2005;174(11) 7446-7452 (Pubitemid 40705717)
16. Uyemura K, Castle SC,Makinodan T.The frail elderly: role of dendritic cells in the susceptibility to infection.Mech Ageing Dev 2002;123(8):955-962. (Pubitemid 34603079)
17. Cossarizza A,Monti D, Cantini M, et al. Extremely low frequency pulsed electromagnetic fields increase interleukin-2 (IL-2) utilization and IL-2 receptor expression in lymphocytes from old subjects. FEBS Lett 1989;248(1-2):141-144. (Pubitemid 19129331)
18. Mo R, Chen J, Han Y, et al. T cell chemokine receptor expression in aging. J Immunol 2003;170(2):895-904. (Pubitemid 36070543)
19. Carson MJ, Sutcliffe JG. Balancing function vs. self defense: the CNS as an active regulator of immune responses. J Neurosci Res 1999;55(1):1-8.
20. Lakkis FG, Sayegh MH. Memory T cells: a hurdle to immunologic tolerance. J Am Soc Nephrol 2003;14(9):2402-2410. (Pubitemid 37052389)
21. CroftM, Bradley LM, Swain SL. Naive versus memory CD4 T cell response to antigen; memory cells are less dependent on accessory cell costimulation and can respond to many APC types including resting B cells. J Immunol 1994;152(6):2675-2685.
22. Dengler TJ, Pober JS. Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J Immunol 2000;164(10):5146-5155. (Pubitemid 30305190)
23. Bingaman AW, Farber DL. Memory T-cells in transplantation: generation, function, and potential role in rejection. Am J Transplant 2004;4(6):846-852. (Pubitemid 38745582)
24. Inbrahim S, Dawson DW, Sanfilippo F. Predominant infiltration of rejecting human renal allografts with T cells expressing CD8 and CD45RO. Transplantation 1995;59:724-728.
25. Kline GH, Hayden TA, Klinman NR. B cellmaintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J Immunol 1999;162(6):3342-3349. (Pubitemid 29313583)
26. Gibson KL,Wu Y-C, Barnett Y, et al. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 2009;8(1):18-25.
27. Colonna-Romano G, Bulati M, Aquino A, et al. B cells in the aged:CD27, CD5, and CD40 expression. Mech Ageing Dev 2003;124(4):389-393. (Pubitemid 36514893)
28. Nossal GJ, Pike BL. Evidence for the clonal abortion theory of B-lymphocyte tolerance. J Exp Med 1975;141(4):904-917.
29. Cambier JC, Kettman JR, Vitetta ES, Uhr JW. Differential susceptibility of neonatal and adultmurine spleen cells to in vitro induction of B-cell tolerance. J ExpMed 1976;144(1):293-297.
30. Metcalf ES, Klinman NR. In vitro tolerance induction of neonatal murine B cells. J Exp Med 1976;143(6):1327-1340.
31. Szewczuk MR, Siskind GW. Ontogeny of B-lymphocyte function. III. In vivo and in vitro studies on the ease of tolerance induction in B lymphocytes from fetal, neonatal, and adult mice. J Exp Med 1977;145(6):1590-1601. (Pubitemid 8123891)
32. LeGuern C. Potential role ofmajor histocompatibility complex class II peptides in regulatory tolerance to vascularized grafts. Transplantation 2004;77(1 Suppl):S35-S37. (Pubitemid 38114418)
33. Le Guern C Regulation of T-cell functions by MHC class II self-presentation. Trends Immunol 2003;24(12):633-638. (Pubitemid 37485912)
34. Benoist C,Mathis D. Regulation ofmajor histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu Rev Immunol 1990;8:681-715. (Pubitemid 20135643)
35. Janick-Buckner D, Briggs CJ,Meyer TE, et al.Major histocompatibility complex antigen expression on lymphocytes fromaging strain Amice. Growth Dev Aging 1991;55(1):53-62.
36. Pietschmann P, Hahn P, Kudlacek S, et al. Surfacemarkers and transendothelial migration of dendritic cells from elderly subjects. Exp Gerontol 2000;35(2):213-224. (Pubitemid 30190086)
37. Herrero C, Sebastían C,Marqúes L, et al. Immunosenescence ofmacrophages: reduced MHC class II gene expression. Exp Gerontol 2002;37(2-3):389-394. (Pubitemid 34073556)
38. Dekruyff RH, Kann EA,Weksler ME, Siskind GW. Effect of aging on T-cell tolerance induction. Cell Immunol 1980;56(1):58-67. (Pubitemid 11243002)
39. Dobken J,WekslerME, Sikind GW. Effect of age on ease of B-cell tolerance induction. CellImmunol 1980;55(1):66-73. (Pubitemid 10005797)
40. Dejaco C, Duftner C, Schirmer M Are regulatory T-cells linked with aging? Exp Gerontol 2006 41 4 339-345
41. Qian T, Ricordi C, Inverardi L, Alejandro R. Intrathymic tolerance and age. Transplant Proc 1995;27(6):3391. (Pubitemid 26016237)
42. Nobori S, Shimizu A, Okumi M, et al.Thymic rejuvenation and the induction of tolerance by adult thymic grafts Proc Natl Acad Sci USA 2006 103 50 19081-19086 (Pubitemid 350002831)
43. Zhao L, Sun L, Wang H, et al. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice. J Leukoc Biol 2007;81(6):1386-1394.
44. Sharma S, Dominguez AL, Lustgarten J. High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J Immunol 2006;177(12):8348-5835.
45. Trzonkowski P, Szmit E,Mýsliwska J,Mýsliwska A. CD4+CD25+T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin Immunol 2006;119(3): 307-316.
46. Hausman PB, Goidl EA, Siskind GW, WekslerME Immunological studies of aging. XI. Age-related changes in idiotype repertoire of suppressor T cells stimulated during tolerance induction. J Immunol 1985;134(6):3802-3807.
47. Tsaknaridis L, Spencer L, Culbertson N, et al. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 2003;74(2):296-308. (Pubitemid 37193716)
48. Kozlowska E, Biernacka M, Ciechomska M, Drela N. Age-related changes in the occurrence and characteristics of thymic CD4+ CD25+ T cells in mice. Immunology 2007;122(3):445-453. (Pubitemid 47556482)
49. Nishioka T, Shimizu J, Iida R, et al. CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice. J Immunol 2006;176(11):6586-6593.
50. Wood KJ. Passenger leukocytes andmicrochimerism: what role in tolerance induction. Transplantation 2003;75(9):17S-20S. (Pubitemid 36593078)
51. Effros R. Costimulatory pathway in the elderly. Vaccine 2000;18(16):1661-1665.
52. Agrawal A, Agrawal S, Tay J, Gupta S. Biology of dendritic cells in aging. J Clin Immunol 2008;28(1):14-20.
53. Ordemann R,Hutchinson R, Friedman J, et al. Enhanced allostimulatory activity of host presenting cells in oldmice intensifies acute graft-versus-host disease. J Clin Invest 2002;109(9):1249-1256. (Pubitemid 34496603)
54. Castle CS, Uyemura K, Crawford W et al Antigen presenting cell function is enhanced in healthy elderly.Mech Ageing Dev 1999 107 2 137-145 (Pubitemid 29138850)
55. Sidman CL, Luther EA, Marschall JD, et al. Increased expression of major histocompatibility complex antigens on lymphocytes fromagedmice. Proc Natl Acad Sci USA 1997;84(21):7624-7628.
56. Della Bella S, Bierti L, Presicce P, et al. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol 2007;122(2):220-228. (Pubitemid 46073895)
57. Varas A, Saced́on R,Hernandez-ĹopezC, et al Age-dependent changes in thymicmacrophages and dendritic cells.Microsc Res Tech 2003 62 6 501-507 (Pubitemid 37467327)
58. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711. (Pubitemid 37174545)
59. Leng Q, Bentwich Z, Borkow G CTLA-4 upregulation during age. Mech Ageing Dev 2002;123(10):1419-1421.
60. Azuma M, Phillips JH, Lanier LL. CD28-T lymphocytes: antigenic and functional properties. J Immunol 1993;150(4):1147-1459.
61. Lio D, D'Anna C, Gervasi F, et al Interleukin-12 release by mitogen-stimulated mononuclear cell in the elderly.Mech Ageing Dev 1998 102 2-3 211-219 (Pubitemid 28353540)
62. Fernandez-Gutierrez B, Jover JA,DeMiguel S, et al. Early lymphocyte activation in elderly humans: impaired T and T-dependent B cell responses. Exp Gerontol 1999;34(2):217-229.
63. Fox A, Harrison LC. Innate immunity and graft rejection. Immunol Rev 2000;173:141-147. (Pubitemid 30095218)
64. Palmer SM, Burch LH, Davis RD, et alThe role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit CareMed 2003;168(6):628-632. (Pubitemid 37175964)
65. Obhrai J, Goldstein DR. The role of toll-like receptors in solid organ transplantation. Transplantation 2006;81(4):497-502.
66. Olszewski WL. Innate immunity processes in organ allografting-their contribution to acute and chronic rejection. Ann Transplant 2005;10(2):5-9.
67. Gomez CR, Boehmer ED, Kovacs EJ. The aging innate immune system. Curr Opin Immunol 2005;17(5):447-462.
68. LaRosa DF, Rahman AH, Turka LA.The innate immune system in allograft rejection and tolerance J Immunol 2007 178 12 7503-7509 (Pubitemid 46898016)
69. Benichou G, Tonsho M, Tocco G, et al. Innate immunity and resistance to tolerogenesis in allotransplantation. Front Immunol 2012;3:73.
70. Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ Aging and innate immune cells. J Leukoc Biol 2004;76(2):291-299. (Pubitemid 39006941)
71. Plowden J, Renshaw-Hoelscher M, Engleman C, et al. Innate immunity in aging: impact on macrophage function. Aging Cell 2004;3(4):161-167. (Pubitemid 40246681)
72. Mishto M, Santoro A, Bellavista E, et al. Immunoproteasomes and immunosenescence. Ageing Res Rev 2003;2(4):419-432. (Pubitemid 37159402)
73. Fulop T, Larbi A, Douziech N, et al. Signal transduction and functional changes in neutrophils with aging. Aging Cell 2004;3(4):217-226. (Pubitemid 40246686)
74. ShawAC, Panda A, Joshi SR, et al.Dysregulation of human Toll-like receptor function in aging Ageing Res Rev 2011 10 3 346-353
75. Tesar BM, Du W, Shirali AC, et al. Aging augments IL-17 T-cell alloimmune responses. Am J Transplant 2009;9(1):54-63.
76. DeMartinis M,ModestiM, LoretoMF, et al. Adhesion molecules on peripheral blood lymphocyte subpopulations in the elderly. Life Sci 2000;68(2):139-151.
77. d'Alessio P. Aging and the endothelium. Exp Gerontol 2004;39(2):165-171. (Pubitemid 38169406)
78. Hoffmann J, Haendeler J, Aicher A, et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 2001;89(8):709-715. (Pubitemid 34627071)
79. Borrego F, Alonso MC, GalianiMD, et al.NK phenotypicmarkers and IL2 response in NK cells from elderly people Exp Gerontol 1999 34 2 253-265 (Pubitemid 29153022)
80. Matzinger P. Tolerance, danger, and the extended family.AnnuRev Immunol Rev 1994;12:991-1045. (Pubitemid 24140436)
81. Park Y,Hirose R, Coatney JL, et al. Ischemia-reperfusion Injury Ismore Severe in Older Versus Young Rat Livers. J Surg Res 2007;137(1):96-102. (Pubitemid 44879438)
82. Okaya T, Blanchard J, Schuster R, et al. Age-dependent responses to hepatic ischemia/reperfusion injury. Shock 2005;24(5):421-427. (Pubitemid 41567353)
83. Verbeke P, Fonager J, Clark BF, Rattan SI. Heat shock response and aging: mechanisms and applications. Cell Biol Int 2001;25(9):845-857. (Pubitemid 32783458)
84. Lee YK,Manalo D, Liu AK.Heat shock response, heat shock transcription factor and cell aging Biol Signals 1996 5 3 180-191 (Pubitemid 26273311)
85. Aschcroft GS, Mills SJ, Ashworth JJ. Ageing and wound healing. Biogerontology 2002;3(6): 337-345.
86. Safirstein RL, Bonventre JV. Molecular response to ischemic and nephrotoxic acute renal failure. In: Molecular Nephrology: kidney function in health and disease. New York: Marcel Dekker; 1995: p. 839.
87. Megyesi J, Udvarhelyi N, Safirstein RL, Price PM.The p53-independent activation of transcription of p21WAF1/CIP1/SDI1 after acute renal failure. AmJ Pathol 1996;271(6):F1211-1216.
88. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000;908:244-254.
89. Chelvarajan RL, Collins SM, Van Willigen JM, Bondada S. The unresponsiveness of aged mice to polysaccharide antigens is a result of a defect in macrophage function. J Leukoc Biol 2005;77(4): 503-512.
90. Gjertson DW. A multi-factor analysis of kidney graft outcomes at one and 5 years posttransplantation: 1996 UNOS update. Clin Transplant 1996;343:360.
91. Terasaki PI,GertsonDW, Cecka JM, et al. Significance of the donor age effect on kidney transplants. Clin Transplant 1997;11:366-372. (Pubitemid 27460429)
92. Tullius SG, Tran H, Guleria I, et al. The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome. Ann Surg 2010;252(4): 662-674.
93. Meier-Kriesche HU, Cibrik DM, Ojo AO, et al Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Soc Nephrol 2002;50(1):14-17 (Pubitemid 34053017)
94. Ojo AO,Wolfe RA, Held PJ, et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997;63(7):968-974. (Pubitemid 27173019)
95. Jassal SW, Olpez G, Cole E. Transplantation in the elderly: a review. Geriatr Nephrol Urol 1997;7(3):157-165.
96. Brandley BA. Rejection and recipient age. Transpl Immunol 2002;10(2-3):125-132.
97. Smits JM, Persijn GG, Van Houwelingen HC. Evaluation of the eurotransplant senior program.The results of the first year. AmJ Transplant 2002;2(7):664-670. (Pubitemid 36306860)
98. Leichtman AB, McCullough KP,Wolfe RA. Improving the allocation system for deceased-donor kidneys. N Engl JMed 2011;364(14):1287-1289.
99. Meier-Kriesche HU, Ojo AO, Cibrik DMet al. Relationship of recipient age and the development of chronic allograft failure. Transplantation 2000;70(2):306-310. (Pubitemid 30602748)
100. SandmanM, Bruunsgaard H, Kemp K, et al Is aging associated with a shift in the balance between type 1 and type 2 cytokines in humans? Clin Exp Immunol 2002 127 1 107-114 (Pubitemid 34155465)
101. Rea IM, McNerlan SE, Alexander HD. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serumTNF-alpha, IFN-gamma, and sIL-2R levels in aging. Exp Gerontol 1999;34(1):79-93. (Pubitemid 29085070)
102. Lou H, Kodama T, Zhao YJ et al. Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC II antigen expression. Circulation 1996;94(12):3355-3361. (Pubitemid 26427509)
103. Weidmann P, Demyttenaere-Bursztein S, Maxwell MH, DeLima J. Effect of aging on plasma renin and aldosterone in normalman. Kidney Int 1975;8(5):325-333.
104. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953;172(4279):603-606.
105. Martins PN. Impact of donor and recipient age on allograft tolerance. Exp Clin Transplant 2009;7(2):67-77.
106. Burnet FM.The clonal selection theory of acquired immunity Nashville, TN: Vanderbilt University Press; 1959.
107. Vetro SW, Bellanti JA. Fetal and neonatal immunoincompetence. Fetal Ther 1989;4(Suppl 1): 82-91.
108. Streilein JW. Neonatal tolerance: towards an immunogenetic definition of self. Immunol Rev 1979;46:123-146.
109. White DJ, Gilks W. The ontogeny of immune responses. J Heart Lung Transplant 1993;12: S301-S308. (Pubitemid 24018963)
110. Ridge JP, Fuchs EJ,Matzinger P.Neonatal tolerance revisited: turning on newborn T-cellswith dendritic cells. Science 1996;271 5256 1723-1726 (Pubitemid 26102819)
111. Ruiz P, Nassiri M, Gregorian S, et al. Neonatal transplantation tolerance is associated with a systemic reduction in memory cells, altered chimeric cell phenotype, and modified ecosanoid and cytokine production. Transplantation 1996;61(8):1198-1205. (Pubitemid 26134770)
112. doCanto FB, Lima Junior C, Teixeira IA, et al. Susceptibility of neonatal T cells and adult thymocytes to peripheral tolerance to allogeneic stimuli. Immunology 2008;125(3):387-396.
113. Hsu HC, Scott DK,Mountz JD Impaired apoptosis and immune senescence-cause or effect? Immunol Rev 2005 205:130-146. (Pubitemid 40780182)
114. Prelog M. Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev 2006;5 2 136-139 (Pubitemid 43129545)
115. Urb́an L, Bessenyei B, Ḿarka M, Semsei I. On the role of aging in the etiology of autoimmunity. Gerontology 2002;48(3):179-184. (Pubitemid 34310075)
116. Habicht GS. Acquired immunological tolerance in aged mice. I. The dose-response relationship. Mech Ageing Dev 1982;19(1):53-62. (Pubitemid 13227924)
117. Ponnappan U, Cinader B, Gerber V, Blaser K. Age-dependent changes in isotype expression and down-regulation of C57BL/6mice. Scand J Immunol 1987;25(1):45-54. (Pubitemid 17144583)
118. Staples PJ, Talal N. Relative inability to induce tolerance in adult NZB and NZB-NZWF1mice. J Exp Med 1969;129(1):123-139.
119. Amagai T, Nakano K, Cinader B. Mechanisms involved in age-dependent decline of immune responsiveness and apparent resistance against tolerance induction in C57BL/6 mice. Scand J Immunol 1982;16(3):217-231. (Pubitemid 12054672)
120. de Faria AM, Ficker SM, Speziali E, et al Aging affects oral tolerance induction but not its maintenance inmice.Mech Ageing Dev 1998 102 1 67-80 (Pubitemid 28256910)
121. Wakabayashi A, Utsuyama M, Hosoda T, et al Differential age effect of oral administration of an antigen on antibody response: an induction of tolerance in young mice but enhancement of immune response in oldmice.Mech Ageing Dev 1999 109 3 191-201 (Pubitemid 29421739)
122. Staples PJ, Steinberg AD, Talal N. Induction of immunologic tolerance in older New Zealand mice repopulated with young spleen, bonemarrow, or thymus. J ExpMed 1970;131(6):1223-1238.
123. Vaz N, Faria MC, Verdolin A, Carvalho CR. Immaturity, ageing and oral tolerance. Scand J Immunol 1997;46:225-229. (Pubitemid 27400225)
124. Gahring LC,Weigle WO.The effect of aging on the induction of humoral and cellular immunity and tolerance in two long-lived mouse strains. Cell Immunol 1990;128(1):142-151. (Pubitemid 20225557)
125. Martins PN, Reutzel-Selke A, Jurisch A, Tullius SG. "Donor and recipient age prevent tolerance induction". World Transplantation Congress (WTC). Am J Transplant 2006;6(Suppl 2):895.
126. Huang X, Sonawane S, Kim J, et al. Age-dependent transplantation tolerance. Abstract 2513 WTC 2006. Am J Transplant 2006;6(Suppl 2):890.
127. Yamada K, Gianello PR, Ierino FL, et al. Role of the thymus in transplantation tolerance in miniature swine: II. Effect of steroids and age on the induction of tolerance to class I mismatched renal allografts. Transplantation 1999;67(3):458-467. (Pubitemid 29094020)
128. Mackall CL, Gress RE.Thymic aging and T-cell regeneration. Immunol Rev. 1997 160:91-102. (Pubitemid 28021369)
129. Arlt W, Hewison M. Hormones and immune function: implications of aging. Aging Cell 2004;3(4):209-216. (Pubitemid 40246685)
130. Taub DD, Longo DL. Insights into thymic aging and regeneration. Immunol Rev 2005;205:72-93. (Pubitemid 40780178)
131. F̈ul̈op T, Larbi A, Hirokawa K, et al. Immunosupportive therapies in aging. Clin Interv Aging 2007;2(1):33-54.
132. Savino W, Postel-Vinay MC, Smaniotto S,Dardenne M.Thethymus gland: a target organ for growth hormone Scand J Immunol 2002 55 5 442-452
133. De Mello-Coelho V, Savino W, Postel-Vinay MC, Dardenne M. Role of prolactin and growth hormone on thymus physiology. Dev Immunol 1998;6(3-4):317-323. (Pubitemid 28517788)
134. Dixit VD, Yang H, Sun Y, et al. Ghrelin promotes thymopoiesis during aging. J Clin Invest 2007;117(10):2778-2790. (Pubitemid 47529609)
135. Bruinsma M, van Soest PL, Leenen PJ, et al. Keratinocyte growth factor induces expansion of murine peripheral CD4+Foxp3+ regulatory T cells and increases their thymic output. J Immunol 2007;179(11):7424-7430.
136. Sportès C, Gress RE. Interleukin-7 immunotherapy. Adv ExpMed Biol 2007;601:321-333.
137. Henson SM, Pido-Lopez J, Aspinall R. Reversal of thymic atrophy. ExpGerontol 2004;39(4):673-678. (Pubitemid 38402096)
138. Wils EJ, Cornelissen JJ.Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement Blood Rev 2005 19 2 89-98
139. Haq AU. 1,25-Dihydroxyvitamin D3 (calcitriol) suppresses IL-2 induced murine thymocyte proliferation. Thymus 1986;8(5):295-306. (Pubitemid 17186691)
140. Vallabhajosyula P, Griesemer A, Yamada K, et al. Vascularized composite islet-kidney transplantation in aminiature swinemodel. Cell Biochem Biophys 2007;48(2-3):201-207. (Pubitemid 47340887)
141. Bluestone JA Regulatory T-cell therapy: is it ready for the clinic? Nat Rev Immunol 2005 5 4 (Pubitemid 40516159)
142. Bluestone JA, Thomson AW, Shevach EM, Weiner HL. What does the future hold for cell-based tolerogenic therapy? Nat Rev Immunol 2007, 7 (8), 650-654 (Pubitemid 47123553)
143. Meyer JM, Archdeacon P, Albrecht R. FDA perspective: enrolment of elderly transplant recipients in clinical trials. Transplantation 2013;95(7):916-918.